Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Finasteride helps female-pattern hair loss.

This study found that androgenic alopecia was associated with a decreased risk of testicular germ cell tumors but a potential increased risk of high-grade prostate cancer.

In this study, autologous platelet concentrates and topical steroids similarly reduced lesion size, Thongprasom scale, and pain in oral lichen planus patients, suggesting autologous platelet concentrates as a potential alternative treatment.

In this study, oral JAK inhibitors were found to be significantly more effective than placebo in promoting hair regrowth among adults and adolescents with moderate-to-severe alopecia areata, although they were associated with an increased risk of adverse events.

This study examined the dementia risk in patients with benign prostatic hyperplasia using alpha-blockers and 5-alpha reductase inhibitors, finding no significant association between these medications and increased dementia risk compared to no treatment, but noted higher risk probabilities for certain 5ARIs.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

This study systematically reviewed the literature on nonsurgical treatments for androgenetic alopecia, such as 5% minoxidil, platelet-rich plasma, and low-level laser therapy, but results on their relative effectiveness were not reported.

This article discusses metformin's potential effects on clinical, metabolic, and hormonal parameters in patients with polycystic ovary syndrome and its role in reducing the risk of diabetes, metabolic syndrome, and cardiovascular disease, but it reports no new clinical results.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

This study concluded that adding Kanglaite injection to gemcitabine and cisplatin chemotherapy for advanced non-small cell lung cancer improved response rates and reduced adverse side effects.

This study found that spironolactone significantly reduced hirsutism scores in women with idiopathic hirsutism compared to finasteride and cyproterone acetate but showed no significant difference among women with PCOS compared to flutamide and finasteride, and it was well tolerated overall.

This review synthesizes existing research on autologous platelet-rich plasma for treating androgenetic alopecia, suggesting its promise with standardized protocols and personalized approaches, but reports no new clinical results.

This study found that in the treatment of androgenetic alopecia, combination therapies involving topical and systemic treatments with adjunctive therapy demonstrated the highest efficacy in improving hair density and diameter compared to placebo, based on a network meta-analysis of 49 randomized controlled trials.

This review discusses the variety of skin disorders associated with atopic dermatitis, exploring their complex relationships and shared genetic and environmental factors, but reports no new clinical results.

This abstract highlights that Hickey and colleagues provided an overview of non-hormonal treatments for menopausal symptoms but missed discussing female pattern hair loss (FPHL), a common issue during menopause.

This study on alopecia areata meta-analyses highlights the risk of misleading results when ineffective, unsafe, or unapproved dosing regimens are included, recommending methodological safeguards to ensure accurate data interpretation and avoid inappropriate causal inferences.

This study highlights that the popular marketing of biotin for hair loss treatment in healthy individuals lacks scientific support, as evidenced by a review of relevant clinical trials.

This study examined the relationship between early-onset androgenetic alopecia and metabolic syndrome, but the abstract does not report specific findings.

This study reviewed various studies and concluded that Janus kinase inhibitors, particularly tofacitinib, seem to promote hair regrowth in about half of patients with alopecia areata, though expected class-specific adverse effects were observed.

This study identified various methodological inconsistencies in systematic reviews on platelet-rich plasma therapy for pattern hair loss, suggesting a need for rigorous adherence to established guidelines.

In this review, the authors reported that past concerns linking spironolactone to an increased risk of breast cancer are unfounded, citing recent studies that confirm no such association, indicating spironolactone's potential as a treatment for alopecia in women without fear of cancer recurrence.

This article discusses adverse event reporting in clinical trials of finasteride for androgenic alopecia and reports no new clinical findings.

This meta-analysis found that laser-based therapies showed promising clinical benefits in treating scarring alopecias, such as disease stabilization and symptom improvement, but highlighted the need for high-quality randomized controlled trials due to serious risk of bias and methodological limitations in existing studies.

This meta-analysis utilized genome-wide association data to explore the genetic traits related to perceived youthfulness across different sex groups in the UK Biobank, incorporating factors like facial aging and lifestyle habits, but the abstract does not report specific results.

This study systematically reviewed meta-analyses and Mendelian randomization studies to identify factors influencing prostate cancer risk, finding suggestive associations for physical activity, height, and smoking but no robust, convincing overlapping evidence across tested factors.